Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-003115 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
221,710
Total Value
$1,901,405.31
P&L
+inf% (+$5,303,704.17)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Grant/Award | 41,000 | $0.00 | $0.00 | 434,802 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Grant/Award | 32,049 | $0.00 | $0.00 | 466,851 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 31,961 | $32.29 | $1,032,110.18 | 434,890 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 13,600 | $33.37 | $453,875.52 | 421,290 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 10,500 | $34.22 | $359,302.65 | 410,790 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 1,600 | $35.07 | $56,116.96 | 409,190 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 91,000 | $0.00 | $0.00 | 91,000 | Direct | โ | View Details |